Bionik Laboratories Corp. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q4 2019 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Bionik Laboratories Corp. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q4 2019 to Q1 2023.
- Bionik Laboratories Corp. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending March 31, 2023 was $501K, a 162% increase year-over-year.
- Bionik Laboratories Corp. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending March 31, 2023 was $1.81M, a 41.7% increase year-over-year.
- Bionik Laboratories Corp. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $1.81M, a 41.7% increase from 2021.
- Bionik Laboratories Corp. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $1.27M, a 6.73% increase from 2020.
- Bionik Laboratories Corp. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2020 was $1.19M, a 44.6% decline from 2019.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Growth (%)